Joined
·
7,295 Posts
A new survey has been posted which aims to gather data based on a diagnosis of IBS-C or Chronic Constipation; the quality of life, the treament and side effects from that treatment.In particular this is in reference to Zelnorm (tegaserod), currently indicated for IBS-constipation predominant sufferers, and going before an FDA Advisory Committee in July 2004 for its new indication of Chronic Constipation.The survey has 9 multiple-choice questions. Results will be published after July 9, when the survey closes.If you experience constipation, please take 5 minutes to complete the survey here: http://www.ibsgroup.org/cgi-local/ubbcgi/u...c;f=31;t=000007 Jeff